FINWIRES · TerminalLIVE
FINWIRES

$HCA

35 stories mentioning HCAUpdated 2d ago

Every FINWIRES story that references HCA, newest first.

Wire

HCA's Health Insurance Exchange Headwinds, Surgical Softness Led to Guidance Reset, RBC Says

HCA Healthcare's (HCA) Q2 results were largely in line with the company's pre-release but Health Insurance Exchange headwinds offsetting a $540 million benefit from a Florida program recognized in the quarter, RBC Capital Markets said in a note emailed Monday.RBC said it was not surprised by HCA Healthcare's resetting of its core earnings before interest, taxes, depreciation, and amortization growth expectations for this year, to "more in line with with the long-term historical 4-6% target" amid the Affordable Care Act headwind as well as "softness" in surgical volumes.The investment firm said that HCA Healthcare's management confirmed that the main drivers of the increased full-year Health Insurance Exchange headwind estimate were two assumptions that did not happen: that about 15% to 20% of people losing exchange coverage would move to employer-sponsored insurance and also that newly uninsured people would show lower hospital utilization.Meanwhile, HCA Healthcare's surgical volume was hit by the disenrollment from Health Insurance Exchange and consumer weakness, RBC said, adding the company saw same-facility inpatient surgeries down 2.3% and outpatient surgeries decreasing 3.4% in the quarter. Also, elective inpatient surgeries fell 6% year-to-date versus a 2% drop last year, RBC said.The investment firm noted, however, that HCA Healthcare's insured volumes, excluding exchanges, rose 3.2% in Q2 and 2.2% year-to-date, which indicates "durable underlying demand."RBC reiterated HCA Healthcare's outperform rating and $435 price target.Price: $391.44, Change: $+9.25, Percent Change: +2.42%

$HCA
Wire

UBS Adjusts HCA Healthcare Price Target to $579 From $635, Maintains Buy Rating

HCA Healthcare Inc (HCA) has an average rating of overweight and mean price target of $465.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $386.71, Change: $+4.41, Percent Change: +1.15%

$HCA
Wire

Bernstein Adjusts HCA Healthcare Price Target to $426 From $413, Maintains Market Perform Rating

HCA Healthcare Inc (HCA) has an average rating of overweight and mean price target of $465.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $390.71, Change: $+8.40, Percent Change: +2.20%

$HCA
Stocks Rise Pre-Bell as Traders Assess New US Tariffs, Latest Middle East Developments
US Markets

Stocks Rise Pre-Bell as Traders Assess New US Tariffs, Latest Middle East Developments

The benchmark US stock measures were trending higher before the open Friday as investors assess Washington's new phase of global tariffs and the latest developments in the Middle East.The S&P 500 and the Nasdaq gained 0.2% each in premarket activity, while the Dow Jones Industrial Average added 0.5%. The indexes ended the previous trading session lower, with the Nasdaq and S&P 500 recording their biggest one-day declines since June 23.In a fact sheet published on Thursday, the Office of the US Trade Representative announced new tariffs of 10% or 12.5% on 60 economies that it said have failed to prohibit or effectively enforce bans on imports made with forced labor, including China, India, the UK and the European Union.The duties took effect at 12:01 a.m. ET Friday, replacing President Donald Trump's temporary 10% global tariffs, which expired at the same time, CNBC reported.Earlier this week, Trump signed three proclamations to impose 50% tariffs on the imports of motor vehicles, alcohol and dairy products from Canada.West Texas Intermediate crude oil dropped 3.5% to $88.99 a barrel before the opening bell, while Brent fell 3.6% to $97.13.Trump told Axios on Thursday that he is seriously considering restarting major combat operations against Iran. The US Central Command said it completed its 13th consecutive night of strikes against Tehran on Thursday.The Iran-backed Houthi militants in Yemen recently claimed attacks on two Saudi Arabian oil tankers in the Red Sea, sparking concerns over a potential closure of the Bab el-Mandeb Strait, an alternate shipping route to the Strait of Hormuz.In a social media post, Trump said the US will hold Iran responsible and threatened "major military punishment" if its Houthi proxies continued to attack commercial ships.Treasury yields were down in premarket action, with the two-year rate retreating 3.4 basis points to 4.33% and the 10-year rate off 2 basis points to 4.68%."Rising oil prices have revived talk of a (Federal Reserve) rate hike, with rates markets now beginning to treat next week's (Federal Open Market Committee) meeting as a live decision after the 10-year yield pushed back toward its year-to-date high," Saxo Bank said in a report Thursday.The probability that the Fed will leave its benchmark lending rate unchanged next week stood at 71% on Friday, up from 66% the day before, according to the CME FedWatch tool. The odds of a quarter-percentage-point increase moved down to 29% from 34%.Shares of Intel (INTC) advanced 5.3% pre-bell after the chipmaker reported second-quarter results ahead of Wall Street's estimates. Oracle (ORCL) inclined 2.6% as the cloud computing giant secured a 10-year enterprise software contract worth nearly $7 billion with the US Department of War.American Express (AXP), Verizon Communications (VZ), HCA Healthcare (HCA), SLB (SLB), Charter Communications (CHTR), Booz Allen Hamilton (BAH) and Lamb Weston (LW) report their latest financial results before the bell, among others.Friday's economic calendar has the S&P Global's (SPGI) flash purchasing managers' index for July at 9:45 am ET, followed by the new home sales report for June at 10 am. The weekly Baker Hughes oil-and-gas rig count is out at 1 pm.Gold nudged up 0.3% to $4,061 per troy ounce, while bitcoin increased 0.2% to $64,949.

Dow JonesNasdaq CompositeS&P 500$AXP$BAH$CHTR$HCA$INTC$LW$ORCL$SLB$SPGI$VZ
Sectors

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell 5.1%.HCA Healthcare (HCA) shares dropped 7.2% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut its price target on the stock to $480 from $500, while keeping its overweight rating.IM8, a nutritional supplements company co-founded by Prenetics Global (PRE) and David Beckham, has lined up about $1 billion in growth financing from General Catalyst, Bloomberg reported. Prenetics shares jumped 17%.NextCure (NXTC) shares almost tripled after the company agreed to merge with privately held Avere Therapeutics in an all-stock deal.

$CTEV$HCA$NXTC$PRE
Wire

Top Midday Decliners

IBM's (IBM) shares sank 25%, the steepest decline on the Dow and the S&P 500, after the tech giant issued Tuesday Q2 guidance below Wall Street expectations.More than 48.8 million shares of the company traded intraday compared with a daily average of about 9.11 million.Jet.AI (JTAI) has entered into a non-binding letter of intent for a proposed business combination with a privately held operating company for a proposed $320 million enterprise value, the company said Tuesday.Shares plunged 21% as intraday trading volume surged to over 1.20 million from the stock's daily average of about 274,000.HCA Healthcare (HCA) lowered its 2026 adjusted diluted EPS guidance on Tuesday. Stephens cut the company's price target to $480 from $500, while keeping its overweight rating.HCA shares slumped 7%, with intraday trading volume at more than 3.04 million versus the stock's daily average of about 1.54 million.Price: $217.46, Change: $-72.78, Percent Change: -25.07%

$HCA$IBM$JTAI
Sectors

Sector Update: Healthcare Stocks Fall Tuesday Afternoon

Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index down 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.8%.The iShares Biotechnology ETF (IBB) was fractionally lower.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell past 11%.HCA Healthcare (HCA) shares dropped 7.3% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut the company's price target to $480 from $500, while keeping its overweight rating.NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock deal to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said. NextCure shares surged 200%.

$CTEV$HCA$NXTC
Sectors

Sector Update: Healthcare

Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each falling 1.8%.The iShares Biotechnology ETF (IBB) was fractionally lower.In corporate news, HCA Healthcare (HCA) shares fell nearly 8% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut the company's price target to $480 from $500, while keeping its overweight rating.

$HCA
Wire

Stephens Adjusts Price Target on HCA Healthcare to $480 From $500, Maintains Overweight Rating

HCA Healthcare (HCA) has an average rating of overweight and mean price target of $490.85, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $364.83, Change: $-25.92, Percent Change: -6.63%

$HCA
Sectors

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3% and the iShares Biotechnology ETF (IBB) 0.1% higher.HCA Healthcare (HCA) shares were down more than 9% after the company cut its 2026 adjusted diluted EPS guidance.NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock transaction to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said. NextCure shares were surging past 313% pre-bell.Spero Therapeutics (SPRO) has licensed exclusive worldwide rights, excluding Greater China, to develop and commercialize Innovent Biologics' immunology drug candidate, IBI355, under a deal valued at up to about $1.1 billion, the companies said. Spero Therapeutics stock was up 0.5% premarket.

$HCA$IBB$NXTC$SPRO$XLV
Commodities

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of Warsh Testimony

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3%, and the actively traded Invesco QQQ Trust (QQQ) advanced 1.1% in Tuesday's premarket activity, ahead of Federal Reserve Chair Kevin Warsh's first day of testimony at 10:00 am ET.US stock futures were mixed, with S&P 500 Index futures down 0.2%, Dow Jones Industrial Average futures slipping 0.6%, and Nasdaq futures gaining 0.4% before the start of regular trading.The US consumer price index fell a seasonally adjusted 0.4% in June, compared with expectations for a 0.1% decline, after rising 0.5% in May, Bureau of Labor Statistics data showed on Tuesday.Fed Governors Michael Barr and Lisa Cook and Fed Vice Chair Michelle Bowman are scheduled to speak on Tuesday.In premarket action, bitcoin was up by 0.9%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 0.9% higher, Ether ETF (EETH) advanced 1.4%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced 1.1%, and the iShares US Technology ETF (IYW) was flat, while the iShares Expanded Tech Sector ETF (IGM) was up 1.9%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was 2% higher, while the iShares Semiconductor ETF (SOXX) rose by 3.5%.IBM (IBM) shares were down more than 22% in premarket activity after the company posted expected Q2 operating earnings and revenue that trailed analysts' estimates.Winners and Losers:Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) retreated 0.3%, the Vanguard Health Care Index Fund (VHT) was up 0.8%, while the iShares US Healthcare ETF (IYH) slipped 0.4%. The iShares Biotechnology ETF (IBB) was 0.3% lower.HCA Healthcare (HCA) stock was down more than 8% premarket after the company cut its guidance for 2026 EPS and revenue.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) rose 0.9%, while the Vanguard Industrials Index Fund (VIS) was up 0.3% and the iShares US Industrials ETF (IYJ) was inactive.General Fusion (GFUZ) was up more than 6% before the opening bell, a day after the company began trading on the Nasdaq following the completion of its merger with Spring Valley Acquisition Corp. III.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) retreated 0.3%. Direxion Daily Financial Bull 3X Shares (FAS) was down 1.2%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 1% higher.JPMorgan Chase (JPM) shares traded down more than 2% in early hours activity even after the company reported higher Q2 earnings and revenue.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was down 0.02%, the Vanguard Consumer Staples Index Fund ETF Shares (VDC) retreated 0.03%, and the iShares US Consumer Staples ETF (IYK) was inactive. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) declined marginally by 0.01%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.6% higher.Honda Motor (HMC) shares were up more than 1% pre-bell after a 0.3% decline at the prior close. The US National Highway Traffic Safety Administration said Monday that the vehicle manufacturer's Odyssey model year 2011 through 2017 vehicles are under review following complaints about airbags deploying unnecessarily.EnergyThe iShares US Energy ETF (IYE) was up 0.3%, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 0.7%.BP (BP) was up more than 1% before market open after the company said its Q2 results are expected to include post-tax adjusting items relating to impairments of around $1.0 billion.CommoditiesFront-month US West Texas Intermediate crude oil advanced by 2.5% to $80.10 per barrel on the New York Mercantile Exchange. Natural gas was down by 0.8% to $2.88 per 1 million British Thermal Units. The United States Oil Fund (USO) was up 2.8%, while the United States Natural Gas Fund (UNG) was 0.3% lower.Gold futures for July gained 0.7% to $4,032.90 an ounce on the Comex. Silver futures advanced by 0.5% to $58.24 an ounce. SPDR Gold Shares (GLD) increased 2.4%, and the iShares Silver Trust (SLV) was 3.2% higher.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$BP$EEM$EETH$EXI$FAS$FAZ$GFUZ$GLD$HCA$HMC$IBB$IBM$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$JPM$PMR$QQQ$RTH$SLV$SOXX$SPY$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Sectors

Sector Update: Healthcare

Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4% and the iShares Biotechnology ETF (IBB) 1.1% higher.HCA Healthcare (HCA) shares were down more than 8% after the company cut its 2026 adjusted diluted EPS guidance.

$HCA
Wire

Stephens Adjusts Price Target on HCA Healthcare to $500 From $530

HCA Healthcare Inc (HCA) has an average rating of overweight and mean price target of $496, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $410.02, Change: $-0.60, Percent Change: -0.14%

$HCA
Sectors

Sector Update: Healthcare Stocks Decline Late Afternoon

Healthcare stocks were lower late Wednesday afternoon, with the NYSE Healthcare Index down 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.1%.The iShares Biotechnology ETF (IBB) fell 1.2%.In corporate news, HCA Healthcare (HCA) shares dropped nearly 3% after Barclays downgraded the stock to equal weight from overweight and cut its price target to $427 from $496.Eli Lilly (LLY) is poised to outpace Q2 consensus sales estimates as strong volume uptake of its weight-loss drug Zepbound and Mounjaro diabetes treatment drives franchise performance, RBC said in a note. RBC raised its price target to $1,500 from $1,250. Lilly shares were down 1.5%.AstraZeneca (AZN) and Daiichi Sankyo are in advanced talks with England's drug pricing regulator to make the breast cancer medicine Enhertu available to some patients, Bloomberg reported. AstraZeneca shares were shedding 1.8%.Universal Health Services (UHS) shares were down over 3% after Barclays downgraded the company's stock to equal-weight from overweight and adjusted the price target to $179 from $238.

$AZN$HCA$LLY$UHS
Sectors

Sector Update: Healthcare

Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index down 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.1%.The iShares Biotechnology ETF (IBB) fell 1.2%.In corporate news, HCA Healthcare (HCA) shares dropped nearly 3% after Barclays downgraded the stock to equal weight from overweight and cut its price target to $427 from $496.

$HCA
Wire

HCA Healthcare Shares Fall After Barclays Downgrade

HCA Healthcare (HCA) shares were down around 2.8% in recent Wednesday trading after Barclays downgraded the stock to equal weight from overweight and cut its price target to $427 from $496.Trading volume stood at over 894,685 shares compared with a daily average of about 1.5 million shares.Price: $411.23, Change: $-11.88, Percent Change: -2.81%

$HCA
Research

Barclays Downgrades HCA Healthcare to Equal Weight From Overweight, Adjusts PT to $427 From $496

HCA Healthcare Inc (HCA) has an average rating of overweight and mean price target of $500.95, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$HCA
Sectors

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks fell late Monday afternoon with the NYSE Health Care Index easing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) losing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, Eli Lilly (LLY) agreed to acquire Ajax Therapeutics for up to $2.3 billion in cash. The deal includes an upfront payment and subsequent payouts based on the achievement of clinical and regulatory milestones. Lilly shares fell 1.6%.HCA Healthcare (HCA) may face pressure through at least H1 as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said. HCA Healthcare shares rose 3.2%.Organon (OGN) shares jumped 17% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $14 a share in cash, valuing the company at $11.75 billion.Moderna (MRNA) is facing a patent infringement lawsuit from CureVac, which alleged that Moderna's COVID-19 vaccine Spikevax used its proprietary mRNA technology without authorization, Reuters reported Saturday. Moderna shares fell 4.7%.

$HCA$LLY$MRNA$OGN
Sectors

Sector Update: Health Care

Health care stocks were lower late Monday afternoon with the NYSE Health Care Index easing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.3%.The iShares Biotechnology ETF (IBB) shed 0.5%.In corporate news, HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said. RBC reiterated its outperform rating and lowered its price target to $534 from $593. HCA Healthcare shares were up 2.3%.

$HCA
Wire

HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says

HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%

$HCA

Showing 1-20 of 35

Track with the FINWIRES app suite

HCA News | FINWIRES